ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AMRN Amarin Corp PLC

0.9013
-0.0167 (-1.82%)
04 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Amarin Corp PLC NASDAQ:AMRN NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  -0.0167 -1.82% 0.9013 0.824 0.94 0.934 0.8911 0.8946 464,012 05:00:04

Amarin to Report Second Quarter 2022 Financial Results and Host Conference Call on August 3, 2022

20/07/2022 1:00pm

GlobeNewswire Inc.


Amarin (NASDAQ:AMRN)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Amarin Charts.

Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin’s senior management team to discuss the Company’s second quarter 2022 financial results on Wednesday, August 3rd, 2022 at 8:00 a.m. ET.

The conference call with management will follow the release of the Company’s second quarter 2022 financial results in the pre-market hours.

Conference Call and Webcast Information:Access to the live call:Go to the investor relations section of the Company's website at www.amarincorp.comDial in within the United States: 888-506-0062International dial in: 973-528-0011Access Code: 316813

Access to replay:Dial in within the United States: 877-481-4010International dial in: 919-882-2331Access Code: 45865A replay of the call will also be available through the Company's website shortly after the call.

About AmarinAmarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From our foundation in scientific research to our focus on clinical trials, and now our commercial expansion, we are evolving and growing rapidly. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk.

Availability of Other Information About Amarin Amarin communicates with its investors and the public using the company website (www.amarincorp.com) and the investor relations website (investor.amarincorp.com), including but not limited to investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin’s investor relations website and may include social media channels. The contents of Amarin’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933. 

Amarin Contact InformationInvestor Inquiries:Lisa DeFrancescoAmarin Corporation plcIR@amarincorp.com (investor inquiries)

Media Inquiries:Mark MarmurAmarin Corporation plcPR@amarincorp.com (media inquiries)

1 Year Amarin Chart

1 Year Amarin Chart

1 Month Amarin Chart

1 Month Amarin Chart

Your Recent History

Delayed Upgrade Clock